Cardinal Health Grows Cardiovascular Portfolio, Biosensors International Expands Reach Through Distribution Agreement

Biosensors International has entered into a strategic agreement that will allow Cardinal Health’s subsidiary Cordis to distribute its portfolio of drug-eluting stents (DES). The partnershipwillimprove Biosensors’ reach in the global cardiovascular market andexpand Cordis’ product offering.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news